Profile: Ivax Pharmaceutical, Inc manufactures & markets brand equivalent (generic) pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers & government agencies in the United States. We make 50 generic medications in about 120 different dosages. We have marketed authorized generic drugs for druggernauts Johnson & Johnson and GlaxoSmithKline. We also produce nutritional and over-the-counter softgel products in an FDA approved facility. Our ONXOL™ (paclitaxel) Injection is a prescription cancer medicine. It is injected into a vein and it is used to treat different types of tumors. The tumors include advanced ovary and breast cancer.

The company was founded in 1986, has revenues of < USD 1 Million, has ~130 employees. NASDAQ:TNOX (SEC Filings)